PHARMEXA INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252
 
  
 
C07K PEPTIDES 3133
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8969542 HPV polyepitope constructs and uses thereofMay 29, 08Mar 03, 15[A61K, C07K]
5679640 Immunosuppressant peptidesMar 08, 95Oct 21, 97[A61K, C07K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2011/0097,352 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsAbandonedOct 30, 07Apr 28, 11[A61K, C12Q, C07K]
2010/0099,613 PEPTIDES FOR INDUCING A CTL AND/OR HTL RESPONSE TO HEPATITIS C VIRUSAbandonedOct 06, 09Apr 22, 10[A61K, A61P]
2010/0068,228 Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid CompositionsAbandonedAug 05, 09Mar 18, 10[A61K, C07H, G01N, A61P, C07K]
2009/0304,746 Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositionsAbandonedOct 31, 07Dec 10, 09[A61K, G01N, A61P, C07K]
7507803 Optimized multi-epitope constructs and uses thereofExpiredOct 03, 03Mar 24, 09[C07H]
2007/0059,799 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsAbandonedSep 18, 06Mar 15, 07[C12Q, C12P]
2007/0014,810 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositionsAbandonedJan 03, 05Jan 18, 07[C07H, A61K, C12Q, C12N, C07K]
2006/0093,617 Peptides for inducing a CTL and/or HTL response to hepatitis C virusAbandonedMay 31, 05May 04, 06[A61K, C07K]
2006/0079,453 Hla binding peptides and their usesAbandonedOct 03, 03Apr 13, 06[A61K]
2006/0018,915 Heteroclitic analogs and related methodsAbandonedApr 07, 03Jan 26, 06[A61K, C07H, C12P, C07K]
2005/0271,676 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositionsAbandonedJan 28, 05Dec 08, 05[C07H, A61K]
2004/0157,273 Subunit vaccines with a2 supermotifsAbandonedApr 09, 04Aug 12, 04[G01N]
2004/0157,780 CTL inducing peptides from c-erb2 (HER-2/neu)AbandonedFeb 04, 04Aug 12, 04[A61K]
6689363 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsExpiredJan 27, 99Feb 10, 04[A61K, C07K]
2003/0216,343 Expression vectors for stimulating an immune response and methods of using the sameAbandonedFeb 21, 03Nov 20, 03[A61K]
2003/0203,869 Expression vectors for stimulating an immune response and methods of using the sameAbandonedFeb 21, 03Oct 30, 03[A61K, C07H]
2003/0185,822 HLA-A2.1 binding peptides and their usesAbandonedApr 03, 02Oct 02, 03[A61K]
2003/0099,634 Compositions and methods for eliciting CTL immunityAbandonedApr 22, 02May 29, 03[A61K, C12N, C07K]
2002/0160,960 HLA binding peptides and their usesAbandonedApr 11, 02Oct 31, 02[A61K]
6413517 Identification of broadly reactive DR restricted epitopesExpiredJan 21, 98Jul 02, 02[A61K, C12Q, C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.